← All trials
NCT02427191
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2015
- Primary completion
- Aug 31, 2018
- Completion date
- Aug 31, 2018
- First posted
- Apr 27, 2015
- Last posted
- Nov 17, 2020
- Enrollment
- 147
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- MiMedx Group, Inc.Lead sponsor
- MedStar Cardiovascular Research NetworkOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.